Introduction
Infantile Cerebral Palsy (ICP) is a descriptive term historically used to group, with therapeutic, epidemiologic and administrative objectives, diverse motor and postural disorders causing limitation in the activity, attributed to nonprogressive disorders that occurred in the brain developing during fetal stage or early infantile stage [1, 2] . Its prevalence is between 1.5 and 3 per 1,000 born alive. It is generally classified as congenital or acquired, according to the time when the brain damage occurred [3] [4] [5] [6] [7] .
Motor syndromes are evident by alterations of posture, of voluntary movements and reflexes, which leads to development of a significant physical disability. These patients present with other alterations of neurodevelopment (convulsions, psychomotor and language slowness, disorders in learning, paying attention and conduct) in different degrees. Clinical manifestations vary according to age of conception, etiology and localization of lesions or anomalies [8) ].
Pathologies associates to ICP are produced before, during or after birth all the same. Approximately 35% of those occurring during birth are due to hypoxia-ischemia (HI), but only between 12 and 23% develop moderate or serious ICP [9, 10] . Those neonates older than 34 weeks gestation who develop ICP of spastic or diskinetic quadriplegia type due to a hypoxiaischemic lesion during birth must present the following evidences:
1. Metabolic acidosis during birth, in the fetus or in arterial blood of the umbilical cord or peripheral blood at birth (pH < 7, deficit of bases > 16 mM/L). 2. Moderate or serious encephalopathy in the first 24 h of life.
Other factors supporting diagnosis of neonatal encephalopathy due to HI during birth are: 1. Presence during birth of a sentinel hypoxic event (rupture of uterus, detachment of placenta, prolapse of the cord, embolism of amniotic liquid, fetal transfusion due to previous vessels or fetal-maternal hemorrhage). 2. Rapid and sustained deterioration of fetal cardiac rate during the sentinel hypoxic event in a fetus with previous normal heart rate. 3. Apgar score from 0 to 6 for more than 5 minutes. 4. Early effect on other organs. 5. Evidences in magnetic resonance (MR) of early cerebral HI -early cerebral edema between 6-12 hours and, mainly, on 4 days of age in the majority of cases at terminus [11] [12] [13] [14] .
Infantile Cerebral Palsy (ICP) is an important health problem which generates great disability in childhood. There are multiple therapeutic alternatives [15] [16] [17] [18] , however, there is scarce available literature to support indication of different therapies for neurorehabilitation and that could aid clinical physicians in recommending them to parents.
Despite medical advances in the fields of obstetric and perinatal medicine, unfortunately, there is no preventive or healing treatment for ICP. Therefore, impossibility to avoid irreversible cerebral lesions in new born with hypoxicischemic encephalopathy and improve clinic alterations of patients with ICP has motivated development of this research to evaluate the efficacy and safety of ozone therapy as alternative treatment in comprehensively dealing with the patient's Static Lesions of the central nervous system (CNS), taking as basis the preclinical and clinical studies carried out in diverse pathologies where the ischemia/reperfusion phenomenon has been present and beneficial results have been obtained, making possible the use of ozone, due to its biologic properties, in patients with Cerebral Palsy to improve their quality of [19] [20] [21] [22] [23] [24] .
Patients and methods
A non-controlled clinical assay was carried out in the Ozone Research Center (CIO) from January 2013 to January 2014.
The study was evaluated by an institutional scientific council and ethics committee, also follow the criteria of declaration of Helsinki.
The sample was made up of patients referred to pediatrics consultation of CIO, to whom the inclusion (children between 1 month and 8 years of age with infantile cerebral palsy of hypoxic-ischemic cause and signed consent of parents to be part of the study) and exclusion criteria (infantile cerebral palsy of other causes, acute infectious diseases, convulsive status) were applied.
Children between 1 month and 8 years with infantile cerebral palsy of hypoxic-ischemic cause remained in the study group. Their parents gave their signed consent being the group constituted by 45 patients. 
Results
As shown in table 1, a 71.1 % of children improved their classification in the Gross Motor Function Classification System scale, which demonstrates that they improved their motor deficit in the clinical exam, achieving a better score in the classification scale due to their motor deficit improvement.
In table 2 we can see how children evolved with this disorder according to manual abilities when carrying out the physical exam. A 46.7 % remained the same and 53.3% improved with respect to their manual abilities. They did not show significant differences related to these percentages, only a trend to improve.
Analyzing 
Total 45 100
Source: Database Table 4 shows the evolution of tone and muscle function in these children, taking into account the parents and physiotherapists' criteria. There we can see that 46.7 % of children had a significant improvement of the tone and muscle function and only 11.1 % maintained without changes in this variable, which backs our hypothesis of evolution related to rehabilitation of the child with infantile cerebral palsy.
Discussion
In Infantile Cerebral palsy we must bear in mind that brain damage is produced by decrease of blood flow to the encephalon affects neurons of different brain areas which intervene in the motor control. These are: primary control area of movement (Pyramidal System), movement modulation centers (Basal Ganglions) and the Cerebellum [25] .
Damage to this group of neurons as a whole, at clinical level evidences diverse anomalies in motor control. It can be observed that movement is affected causing tremor, dyskinesia, dystonia and [25] .
Encephalon has a blood flow of 45 to 55 milliliters per minute per 100 grams of weight for white substance; it has 70 to 90 milliliters per minute per 100 In our study, patients included proved a diagnosis of Infantile Cerebral Palsy of Hypoxic-Ischemic cause. For the result analysis, we must take into account some aspects of physiopathology of cerebral ischemia. For example, during cerebral ischemia, production of adenosine triphosphate (ATP) is reduced affecting the activity of Calcium ATP-ase enzyme. As a result, there is an abnormal increase of concentrations of this ion within the neuron leading to the release of excitatory neurotransmitters, such as glutamate (greatly responsible for excitotoxicity phenomena), release of free radicals in the ischemic cerebral tissue and inhibition of ATP production [27] . It is known that during cerebral ischemia there is production of abnormal high concentrations of reactive oxygen species (ROS), among which are the superoxide anion (O2.-), the hydroxyl radical (OH-), nitric oxide (NO) and peroxynitrite anion (ONOO-); all of them involved in neurodamage occurring during ischemia [27, 28] . Also, in cerebral ischemia there is overstimulation of phospholipase A2, responsible of increase of degradation products of membrane phospholipids. These products accumulate and can turn into a platelet activating factor with an enhancement effect of platelet aggregation and inducer of inflammatory response by means of leukocytes adhesion and aggregation, hindering the passage of the blood flow to the encephalon [28] .
In addition, during decrease of cerebral blood flow an inflammatory gene expression is induced in different types of cells causing release of proinflammatory cytokines [27] [28] . Interleukin 1-β (IL-β) and tumor necrosis factor α (TNF-α) are the cytokines that start the inflammatory response and interleukin 6 (IL-6) is the one that mediates the late inflammatory response in ischemic cerebral tissue [29] . IL-6 and TNF-α stimulate production of metalloproteinase, specifically the MMP-9. This metalloproteinase is responsible for alteration of the blood-brain barrier conditioning the occurrence of vascular edema and contributing to hemorrhagic transformation of infarct [29] .
Beginning with the interpretation of the results obtained, for quantitative description of the motor function, in our study we used the GMFCS classification system, a tool that determines the degree of motor function limitation of patients with ICP [30, 31] .
With respect to distribution at encephalic level of some antioxidants, it is known that vitamin E concentration in the cerebellum is low. On the other hand, it has been demonstrated that antioxidant enzymes like catalase have a lower concentration in the brain in relation to other tissues.
The most studied excitotoxin is glutamate. In physiologic conditions it is an excitatory neurotransmitter. However, excessive levels turn out to be toxic and determine the death of retinal ganglion cells [30] . The term excitotoxicity is stamped to describe this effect (Exciter + toxic = Excitotoxin) [31] .
A high local concentration of glutamate stimulates receptors of the cell surface, mainly the N-methyl-D-aspartate (NMDA), which opens the calcium channels, determining an intracellular overcharge of this ion with the subsequent activation of the nitric oxide synthase enzyme, which generates the nitric oxide with free radical properties. Glutamate, as well as nitric oxide, are neurotransmitters in normal conditions. However, when NMDA receptors are hyper stimulated, the nitric oxide combines with reactive mediators to oxygen generating peroxynitrates that produce nitrosylation and fragmentation of DNA [32] .
With respect to spasticity, bulbar reticular formation inhibits the muscle tone, the inhibitory bulboreticular region receives orders from the motor cortex, anterior lobule of cerebellum and the basal ganglions. The exciter way of muscle tone is the medial reticule spinal fascicle from the bridge, that is, from reticular formation of the bridge.
There must be a balance between the excitatory and inhibitory ways of the muscle tone. For example, a lesion in the cortical-bulbar fibers at cortex level, or in an internal capsule it reduces inhibition of the muscle tone, in which a supremacy of the excitatory ways is produced with occurrence of spasticity [28] [29] [30] 33] .
Ozone oxidative pre/post-conditioning is an ozone's mechanism of action which has been demonstrated from experimental and clinical point of view [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] . Ozone therapy promotes a slight and transient oxidative stress through its capacity to ¨trigger¨ antioxidant endogenous system in order to re-establish antioxidant/pro-oxidant balance preserving mitochondrial integrity and superoxide dismutase activities [37, 39] . Ozone is able to reestablished the cellular redox balance with a significant reduction in oxidative stress, which is one of the main processes unleashing the pathological cascade that induces protein injury in cerebral palsy of hypoxic-ischemic cause. On the other hand, the decrease in phospholipase A2 (PLA2) activity after ozone treatment suggests the reduction in inflammatory mediators produced in the arachidonic acid cascade [19, 20, 22, 23] . Ozone protected against protein damage through regulation of ROS, preserving mitochondrial integrity and functionality [37, 42] . Moreover, in experimental models studied, levels of nitric oxide, pro inflammatory cytokines, like the tumor necrosis factor (TNF-α) and interleukin 1 and 6, protease calcium-dependent activity, as well as overexpression of nuclear factor-kappa-B activity, were able to be modulated by ozone treatment [36, [38] [39] [40] 43] . Another aspect to be taken in consideration is the role of ozone in activating A1 adenosine receptors [21] . Adenosine, acting on presynaptic A1 receptors, is able to inhibit glutamate release at excitatory synapses and, thus counteracts the neuronal hyper excitability that occurs during cerebral ischemia and spasticity [1, [46] [47] [48] . Ozone´s beneficial effects suggest that ozone is able to achieve a balance between γ-aminobutyric acid (GABA), the primary inhibitory neurotransmitter, and glutamate, the major excitatory neurotransmitter [49, 50] .
All these physiopathologic mechanisms associated to infantile cerebral palsy of hypoxic-ischemic cause explain the positive results in our patients after the ozone treatment mainly based on its effect, a stimulant of the antioxidant defense system of the organism, improving the oxygen contribution to the brain tissue and to the rest of the body by increasing the blood flow and acting as a neuroprotective agent.
Conclusions
It was observed that the highest percentage of patients improved in the evolution of motor disorder according to the Gross Motor Function Classification scale. At applying the Manual Ability Classification System (MACS) scale, more than half the patients evidenced an improvement. On the other hand, the highest percentage of patients showed a significant improvement in muscle tone and motor function. No side effects were observed during the study. We recommend the application of Ozone therapy in the rehabilitation of children with cerebral palsy of hypoxic-ischemic cause and also in order to encouraging the results of this study support further confirmatory clinical trials.
